12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens

por Luetkemeyer, Anne F., McDonald, Cheryl, Ramgopal, Moti, Noviello, Stephanie, Bhore, Rafia, Ackerman, Peter
Publicado 2016

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor

por Fisher, Martin, McDonald, Cheryl, Moyle, Graeme, Martorell, Claudia, Ramgopal, Moti, Laplante, Francois, Curley, Joanne, Graham, Hiba, Tran-Muchowski, Cecilia, Liu, Yapei, Rhee, Martin, Szwarcberg, Javier
Publicado 2014

1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K, Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn, Ramgopal, Moti, McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E, Brainard, Diana M, Martin, Hal
Publicado 2020

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K., Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn O., Ramgopal, Moti N., McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E., Brainard, Diana M., Martin, Hal
Publicado 2021

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease...

por Eron, Joseph J, Lelievre, Jean-Daniel, Kalayjian, Robert, Slim, Jihad, Wurapa, Anson K, Stephens, Jeffrey L, McDonald, Cheryl, Cua, Eric, Wilkin, Arjun, McKellar, Mehri, Cox, Stephanie, Majeed, Sophia, Blair, Christiana, Carter, Christoph C, SenGupta, Devi, Brainard, Diana M, Das, Moupali
Publicado 2019